Cordova Ashley (CIK 1822014) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-05). Recent activity: Sell NVCR (17,638 shares), Sell NVCR (11,541 shares), Buy NVCR (23,818 shares), Sell NVCR (2,410 shares), Sell NVCR (7,228 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | NovoCure Ltd (NVCR) | Former Chief Executive Officer | Sell | 17,638 | $234,585 |
| 2026-03-03 | NovoCure Ltd (NVCR) | Former Chief Executive Officer | Sell | 11,541 | $158,689 |
| 2026-03-03 | NovoCure Ltd (NVCR) | Former Chief Executive Officer | Buy | 23,818 | $0 |
| 2026-03-03 | NovoCure Ltd (NVCR) | Former Chief Executive Officer | Sell | 2,410 | $32,945 |
| 2026-03-03 | NovoCure Ltd (NVCR) | Former Chief Executive Officer | Sell | 7,228 | $98,807 |
| 2025-09-08 | NovoCure Ltd (NVCR) | Chief Executive Officer | Buy | 81,550 | $996,541 |
| 2025-07-01 | NovoCure Ltd (NVCR) | Chief Executive Officer | Buy | 833 | $12,603 |
来源：SEC Form 4 申报文件 · 截至 2026-03-05